參考文獻(xiàn)/References:
[1] Lee D W,Kim M S,Lim Y H,et al.Prenatal and postnatal exposure to di-(2-ethylhexyl)phthalate and neurodevelopmentaloutcomes:a systematic review and meta-analysis[J].Environ Res,2018,167:558-566.
[2] Fan Y,Qin Y,Chen M,et al.Prenatal low-dose DEHP exposure induces metabolic adaptation and obesity:Role ofhepatic thiamine metabolism[J].J Hazard Mater,2020,385:121534.
[3] Gao N,Hu R,Huang Y,et al.Specific effects of prenatal DEHP exposure on neuroendocrine gene expression in thedeveloping hypothalamus of male rats[J].Arch Toxicol,2018,92(1):501-512.
[4] Rusyn I,Peters J M,Cunningham M L.Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in theliver[J].Crit Rev Toxicol,2006,6(5):459-479.
[5] Gupta R K,Singh J M,Leslie T C,et al.Di-(2-ethylhexyl)phthalate and mono-(2-ethylhexyl)phthalate inhibit growth and reduce estradiol levels of antral follicles in vitro[J].Toxicol Appl Pharmacol,2010,242(2):224-230.
[6] Koch H M,Bolt H M,Preuss R,et al.New metabolites of di(2-ethylhexyl)phthalate(DEHP)in human urine and serumafter single oral doses of deuterium-labelled DEHP[J].Arch Toxicol,2005,79(7):367-376.
[7] Mariana M,Feiteiro J,Cairrao E.Cardiovascular response of rat aorta to di-(2-ethylhexyl)phthalate(DEHP)exposure[J].Cardiovasc Toxicol,2018,18(4):356-364.
[8] Campbell Jr J L,Yoon M,Ward P,et al.Excretion of di-2-ethylhexyl phthalate(DEHP)metabolites in urine is related to body mass index because of higher energy intake in the overweight and obese[J].Environ Int,2018,113:91-99.
[9] Zhu F.Research progress of biotoxicity and control strategy of plasticizer DEHP[J].Shanxi Chemical Industry,2020,40(4):29-30,33.
[10] Ha M,Guan X,Wei L,et al.Di-(2-ethylhexyl)phthalate inhibits testosterone level through disturbed hypothalamic-pituitary-testis axis and ERK-mediated 5alpha-reductase 2[J].Sci Total Environ,2016:563-564,566-575.
[11] Goudarzi M,Haghi Karamallah M,Malayeri A,et al.Protective effect of alpha-lipoic acid on di-(2-ethylhexyl)phthalate-induced testicular toxicity in mice[J].Environ Sci Pollut Res Int,2020,27(12):13670-13678.
[12] Kalo D,Vitorino C A,Archilla C,et al.Mono(2-ethylhexyl)phthalate(MEHP)induces transcriptomicalterations in oocytes and their derived blastocysts[J].Toxicology,2019,421:59-73.
[13] Jacobs H M,Sant K E,Basnet A,et al.Embryonic exposure to mono(2-ethylhexyl)phthalate(MEHP)disruptspancreatic organogenesis in zebrafish(Danio rerio)[J].Chemosphere,2018,195:498-507.
[14] Qi W,Xu Q,Xu Y,et al.Effect of notch pathway on lipid accumulation induced by mono-2-ethylhexylphthalate on 3T3-L1 cells[J].Ecotoxicol Environ Saf,2021,208:111472.
[15] Hlisnikova H,Petrovicova I,Kolena B,et al.Effects and mechanisms of phthalates action on reproductive processesand reproductive health:a literature review[J].Int J Environ Res Public Health,2020,17(18):6811.
[16] Dong Ruina L S,Zhang M,et al.Effect of DEHP on the expression levels of Bax and Bcl-2 in mouse spermatogonialcells[J].Journal of Ecotoxicology,2017,12(5):270-277.
[17] Shao P,Wang Y,Zhang M,et al.The interference of DEHP in precocious puberty of females mediated by thehypothalamic IGF-1/PI3K/Akt/mTOR signaling pathway[J].Ecotoxicol Environ Saf,2019,181:362-369.
[18] de Roux N,Genin E,Carel J C,et al.Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derivedpeptide receptor GPR54[J].Proc Natl Acad Sci U S A,2003,100(19):10972-10976.
[19] Seminara S B,Messager S,Chatzidaki E E,et al.The GPR54 gene as a regulator of puberty[J].N Engl J Med,2003,349(17):1614-1627.
[20] Ruohonen S T,Poutanen M,Tena-Sempere M.Role of kisspeptins in the control of the hypothalamic-pituitary-ovarianaxis:old dogmas and new challenges[J].Fertil Steril,2020,114(3):465-474.
[21] Ibrahim R O,Omer S H,Fattah C N.The Correlation between hormonal disturbance in PCOS women and serum level of kisspeptin[J].Int J Endocrinol,2020:6237141.
[22] Padda J,Khalid K,Moosa A,et al.Role of Kisspeptin on hypothalamic-pituitary-gonadal pathology and its effect onreproduction[J].Cureus,2021,13(8):e17600.
[23] Lopez-Rodriguez D,Franssen D,Bakker J,et al.Cellular and molecular features of EDC exposure:consequences forthe GnRH network[J].Nat Rev Endocrinol,2021,17(2):83-96.
[24] Tao Ailin Z X,Feng X L.Research progress of Kisspeptin in the treatment of polycystic ovary syndrome[J].Advances in Modern Obstetrics and Gynecology,2022,31(9):714-717.
[25] Patterson M,Murphy K G,Thompson E L,et al.Administration of kisspeptin-54 into discrete regions of the hypothalamus potently increases plasma luteinising hormone and testosterone in male adult rats[J].J Neuroendocrinol,2006,18(5):349-354.
[26] Wassenaar P N H,Legler J.Systematic review and meta-analysis of early life exposure to di(2-ethylhexyl)phthalate and obesity related outcomes in rodents[J].Chemosphere,2017,188:174-181.
[27] Veiga-Lopez A,Pu Y,Gingrich J,et al.Obesogenic endocrine disrupting chemicals:identifying knowledge gaps[J].Trends Endocrinol Metab,2018,29(9):607-625.
[28] Sol C M,Santos S,Duijts L,et al.Fetal phthalates and bisphenols and childhood lipid and glucose metabolism.A population-based prospective cohort study[J].Environ Int,2020,144:106063.
[29] Sohn J W.Network of hypothalamic neurons that control appetite[J].BMB Rep,2015,48(4):229-233.